SPONSORIZED PARTNERS

Regeneron says its Covid-19 antibody treatment cut medical visits in trial

Regeneron Pharmaceuticals said Wednesday its coronavirus antibody cocktail, the experimental treatment that President Donald Trump received, significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate Covid-19. Regeneron said patients given the treatment, REGN-COV2, made around 57 percent fewer Covid-19-related medical visits than those given a...

Continue reading

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?